Roivant Sciences (ROIV) EBT Margin Growth (1y) (2021 - 2025)
Roivant Sciences (ROIV) EBT Margin Growth (1y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,526.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,558.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -683.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 452.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Roivant Sciences | 24.35 Bn | 25.12 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.03 Mn |
| Sep 30, 2025 | -510,960.00 |
| Jun 30, 2025 | -1.22 Mn |
| Dec 31, 2024 | -2.40 Mn |
| Sep 30, 2024 | 160,334.00 |
| Jun 30, 2024 | 126,221.00 |
| Dec 31, 2023 | 2.48 Mn |
| Sep 30, 2023 | -411,405.00 |
| Jun 30, 2023 | 659,074.00 |
| Dec 31, 2022 | -171,143.00 |
| Sep 30, 2022 | -89,309.00 |
| Jun 30, 2022 | -679,319.00 |
| Dec 31, 2021 | 342,426.00 |
| Sep 30, 2021 | 237,960.00 |
| Jun 30, 2021 | -87,688.00 |